By David Cassak
The ability to bring an active therapeutic profile to an otherwise inert medical device is an important part of what...
Most medical device start-ups seeking to tap into the enormous drug-eluting stent market have focused on novel stent or stent platform design, on the theory that drug efficacy is a given. But X-Cell Medical is betting that they've come up with a better drug. And they're making their case by stressing the importance of safety.
By David Cassak
The ability to bring an active therapeutic profile to an otherwise inert medical device is an important part of what...